Brain metastasis therapeutics sales will expand through 2035, with therapies using medication at 40% of treatment type demand and hospitals at 60% of end user demand in 2025. The market was valued at USD 4.28 billion in 2025 and is projected to reach USD 8.82 billion by 2035 at a 7.5% CAGR.